Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype

Abstract Background Neoadjuvant systemic therapy (NST) is a widely accepted initial treatment modality that can lead to pathologic downstaging of the axillary disease burden in breast cancer patients. Axillary response as well as baseline 18F-fluorodeoxyglucose (18F-FDG) uptake on positron emission...

Full description

Saved in:
Bibliographic Details
Main Authors: Cornelis M. de Mooij, Cristina Mitea, Felix M. Mottaghy, Marjolein L. Smidt, Thiemo J. A. van Nijnatten
Format: article
Language:EN
Published: SpringerOpen 2021
Subjects:
Online Access:https://doaj.org/article/b13c01bea3fc48809b4b52ec335574e5
Tags: Add Tag
No Tags, Be the first to tag this record!